826 results on '"Thornalley, Paul J."'
Search Results
102. Analysis of glucosinolates, isothiocyanates, and amine degradation products in vegetable extracts and blood plasma by LC–MS/MS
103. Glycation- and/or Polyol Pathway-Inducing Complications
104. Activation of NF-E2–Related Factor-2 Reverses Biochemical Dysfunction of Endothelial Cells Induced by Hyperglycemia Linked to Vascular Disease
105. Reversal of Hyperglycemia-Induced Angiogenesis Deficit of Human Endothelial Cells by Overexpression of Glyoxalase 1 In Vitro
106. Preparation of Nucleotide Advanced Glycation Endproducts—Imidazopurinone Adducts Formed by Glycation of Deoxyguanosine with Glyoxal and Methylglyoxal
107. The Dicarbonyl Proteome: Proteins Susceptible to Dicarbonyl Glycation at Functional Sites in Health, Aging, and Disease
108. Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE) - an introduction
109. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins
110. Glycation in diabetic neuropathy: Characteristics, consequences, causes, and therapeutic options
111. Increased Dicarbonyl Metabolism in Endothelial Cells in Hyperglycemia Induces Anoikis and Impairs Angiogenesis by RGD and GFOGER Motif Modification
112. Reversal of Biochemical Dysfunction in Endothelial Cells in Hyperglycemia by Induction of Antioxidant Response Element-Linked Gene Expression by Sulforaphane: 785-P
113. Peptide mapping of type IV collagen modified minimally by methylglyoxal in vitro reveals mechanism of cell-matrix disruption
114. A simplified method for the purification of human red blood cell glyoxalase. I. Characteristics, immunoblotting, and inhibitor studies
115. Glycated and Oxidized Protein Degradation Products Are Indicators of Fasting and Postprandial Hyperglycemia in Diabetes
116. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimerʼs disease and link to cognitive impairment
117. Increased Protein Glycation in Cirrhosis and Therapeutic Strategies to Prevent It
118. High-Dose Thiamine Therapy Counters Dyslipidemia and Advanced Glycation of Plasma Protein in Streptozotocin-Induced Diabetic Rats
119. Peptide Mapping of Human Serum Albumin Modified Minimally by Methylglyoxal in Vitro and in Vivo
120. Dicarbonyl Intermediates in the Maillard Reaction
121. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis
122. Nϵ-(Carboxymethyl)lysine and 3-DG-Imidazolone Are Major AGE Structures in Protein Modification by 3-Deoxyglucosone
123. Prevention of Incipient Diabetic Nephropathy by High-Dose Thiamine and Benfotiamine
124. Increased formation of methylglyoxal and protein glycation, oxidation and nitrosation in triosephosphate isomerase deficiency
125. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts
126. Mass spectrometric monitoring of albumin in uremia
127. Reading patterns of proteome damage by glycation, oxidation and nitration: quantitation by stable isotopic dilution analysis LC-MS/MS
128. Urinary Metabolomic Markers of Protein Glycation, Oxidation, and Nitration in Early-Stage Decline in Metabolic, Vascular, and Renal Health
129. ELECTRON SPIN RESONANCE AND SPIN TRAPPING
130. Teratogenicity of 3-Deoxyglucosone and Diabetic Embryopathy
131. Idiopathic hypoalbuminemia explained by reduced synthesis rate and an increased catabolic rate
132. Amino Acids Glycation Section
133. Involvement of glutathione metabolism in the cytotoxicity of the phenethyl isothiocyanate and its cysteine conjugate to human leukaemia cells in vitro
134. Studies on the mechanism of the inhibition of human leukaemia cell growth by dietary isothiocyanates and their cysteine adducts in vitro
135. Kinetics and mechanism of the reaction of aminoguanidine with the α-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions
136. Special edition of Amino Acids of selected papers from the eleventh international symposium on the Maillard reaction, September 16–20, 2012
137. Glyoxalase 1 Modulation in Obesity and Diabetes
138. Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage
139. Studies of advanced glycation end products and oxidation biomarkers for type 2 diabetes
140. Accumulation of α-oxoaldehydes during oxidative stress: a role in cytotoxicity
141. Glycation- and/or Polyol Pathway-Inducing Complications
142. Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET)
143. 285. PROTEIN OXIDATION, NITRATION AND GLYCATION FREE ADDUCTS: BIOMARKERS FOR EARLY-STAGE DIAGNOSIS AND TYPING OF ARTHRITIS
144. 192. INCREASED PROTEIN GLYCATION, OXIDATION AND NITRATION WITH INCREASING SEVERITY OF RHEUMATOID ARTHRITIS IN A CROSS-SECTIONAL STUDY ASSESSED BY ROBUST STABLE ISOTOPIC DILUTION ANALYSIS QUANTITATION
145. Biomarker combination detects early-stage and discriminates osteoarthritis, rheumatoid arthritis and other inflammatory joint disease\ud
146. Glyoxalase 1-knockdown in human aortic endothelial cells – effect on the proteome and endothelial function estimates
147. Reappraisal of putative glyoxalase 1-deficient mouse and dicarbonyl stress on embryonic stem cellsin vitro
148. Quantitation of plasma thiamine, related metabolites and plasma protein oxidative damage markers in children with autism spectrum disorder and healthy controls
149. Protein oxidation, nitration and glycation biomarkers for early-stage diagnosis of osteoarthritis of the knee and typing and progression of arthritic disease
150. Glycation of Proteins
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.